HUSSMAN STRATEGIC ADVISORS, INC. – CRISPR Therapeutics AG Transaction History
HUSSMAN STRATEGIC ADVISORS, INC. portfolio value:
$680,000
portfolio value
HUSSMAN STRATEGIC ADVISORS, INC. quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -50.00% | -10.4K shares | -584K | $65.35 | 10.4K |
| Q2 2022 | share | Increase | +100.00% | 10.4K shares | 611K | $60.77 | 20.8K |
| Q1 2022 | share | 0.00% | 0 shares | -135K | $62.77 | 10.4K | |
| Q4 2021 | share | Decrease | -16.13% | -2K shares | -600K | $78.85 | 10.4K |
| Q3 2021 | share | Increase | +33.33% | 3.1K shares | -118K | $111.93 | 12.4K |
| Q2 2021 | share | Increase | +158.33% | 5.7K shares | 1.06M | $161.89 | 9.3K |
| Q1 2021 | share | Decrease | -64.71% | -6.6K shares | -1.12M | $121.85 | 3.6K |
| Q4 2020 | share | Decrease | -66.67% | -20.4K shares | -997K | $153.11 | 10.2K |
| Q3 2020 | share | Increase | +99.35% | 15.25K shares | 1.43M | $83.64 | 30.6K |
| Q2 2020 | share | 0.00% | 0 shares | 477K | $73.49 | 15.35K | |
| Q1 2020 | share | Increase | +49.76% | 5.1K shares | 27K | $42.41 | 15.35K |
| Q4 2019 | share | Increase | 0.00% | 10.25K shares | 624K | $60.91 | 10.25K |